Related Experiment Video
Updated: Jan 28, 2026

Measuring DNA Damage and Repair in Mouse Splenocytes After Chronic In Vivo Exposure to Very Low Doses of Beta- and Gamma-Radiation
Published on: July 3, 2015
Inhibition of Nuclear PTEN Tyrosine Phosphorylation Enhances Glioma Radiation Sensitivity through Attenuated DNA
Jianhui Ma1, Jorge A Benitez1, Jie Li2
1Ludwig Institute for Cancer Research, San Diego Branch, University of California at San Diego, 9500 Gilman Drive, La Jolla, CA 92093-0660, USA.
Abstract:
Ionizing radiation (IR) and chemotherapy are standard-of-care treatments for glioblastoma (GBM) patients and both result in DNA damage, however, the clinical efficacy is limited due to therapeutic resistance. We identified a mechanism of such resistance mediated by phosphorylation of PTEN on tyrosine 240 (pY240-PTEN) by FGFR2. pY240-PTEN is rapidly elevated and bound to chromatin through interaction with Ki-67 in response to IR treatment and facilitates the recruitment of RAD51 to promote DNA repair. Blocking Y240 phosphorylation confers radiation sensitivity to tumors and extends survival in GBM preclinical models. Y240F-Pten knockin mice showed radiation sensitivity. These results suggest that FGFR-mediated pY240-PTEN is a key mechanism of radiation resistance and is an actionable target for improving radiotherapy efficacy.
Insights
Glioblastoma treatment resistance to radiation therapy involves PTEN phosphorylation. Blocking this mechanism enhances tumor sensitivity to radiation, improving survival in preclinical models.
Area of Science:
- Oncology
- Molecular Biology
- Radiotherapy
Background:
- Standard glioblastoma treatments like ionizing radiation (IR) and chemotherapy are limited by therapeutic resistance.
- DNA damage is a hallmark of these treatments, but resistance mechanisms hinder clinical efficacy.
Purpose of the Study:
- To identify the molecular mechanisms underlying therapeutic resistance in glioblastoma.
- To investigate the role of PTEN phosphorylation in radiation resistance.
- To explore FGFR2 as a potential therapeutic target.
Main Methods:
- Investigated the phosphorylation of PTEN on tyrosine 240 (pY240-PTEN) mediated by FGFR2.
- Assessed the binding of pY240-PTEN to chromatin via Ki-67 interaction post-IR.
- Evaluated the recruitment of RAD51 to DNA damage sites.
- Utilized Y240F-Pten knockin mice and GBM preclinical models to test therapeutic interventions.
Main Results:
- Identified FGFR2-mediated phosphorylation of PTEN at tyrosine 240 (pY240-PTEN) as a key mechanism of IR resistance.
- Demonstrated that pY240-PTEN rapidly elevates and binds to chromatin with Ki-67 in response to IR, promoting DNA repair via RAD51 recruitment.
- Showed that blocking Y240 phosphorylation confers radiation sensitivity and extends survival in GBM preclinical models.
- Confirmed radiation sensitivity in Y240F-Pten knockin mice.
Conclusions:
- FGFR-mediated pY240-PTEN is a critical driver of radiation resistance in glioblastoma.
- Targeting FGFR-mediated pY240-PTEN represents a promising strategy to enhance radiotherapy efficacy.
- Inhibition of this pathway offers a potential therapeutic avenue for improving patient survival.
Related Concept Videos
Overview of DNA Repair
Chemically...
Overview of DNA Repair
Phosphorylation
During phosphorylation, protein kinases transfer the terminal phosphate group of ATP to specific amino acid side chains of substrate proteins. Serine, threonine, and tyrosine are the most commonly...
Long-patch Base Excision Repair
Biological Effects of Radiation
Nuclear Overhauser Enhancement (NOE)

